{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T23:24:38Z","timestamp":1770420278352,"version":"3.49.0"},"reference-count":50,"publisher":"IMR Press","issue":"9","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Background: Some patients with hypertrophic obstructive cardiomyopathy (HOCM) still exhibit systolic anterior motion (SAM) and mitral regurgitation (MR) even after undergoing an isolated ventricular septectomy. Currently, there are disputes regarding whether to perform a mitral valve intervention and which type of operation is more effective. Methods: By searching PubMed, Cochrane, Embase, Web of Science, FDA.gov, and ClinicalTrials.gov, as well as other resource databases, we obtained all articles published before December 2022 on ventricular septal myectomy combined with mitral valve intervention for hypertrophic cardiomyopathy. Demographic information and outcome variable data were extracted from 10 screened studies on ventricular septal resection combined with mitral valve repair. The risk of bias was assessed using methodological index for non-randomized studies (MINORS). Student\u2019s t-test was used for comparisons of continuous variables, and the chi-square or Fisher\u2019s exact test was used for dichotomous variables. A total of 692 patients across 10 studies were analyzed. Results: There were 5 (0.7%) deaths in the perioperative period. The average cardiopulmonary bypass time was 64.7 \u00b1 22.2 minutes, and the average follow-up time was 39.6 \u00b1 36.3 months. Compared with baseline levels, the left ventricular outflow tract gradient (83.6 \u00b1 32.2 mmHg vs. 11.0 \u00b1 7.8 mmHg, p &lt; 0.01), maximum interventricular septal thickness (22.5 \u00b1 5.1 mm vs. 14.7 \u00b1 5.5 mm, p &lt; 0.01), III\/IV mitral regurgitation (351\/692 vs. 17\/675, p &lt; 0.01), anterior mitral leaflet (AML)-annulus ratio (0.49 \u00b1 0.14 vs. 0.60 \u00b1 0.12, p &lt; 0.01), tenting area (2.72 \u00b1 0.60 cm2 vs. 1.95 \u00b1 0.60 cm2, p &lt; 0.01), and SAM (181\/194 vs. 11\/215, p &lt; 0.01) were significantly improved. 14 (2.1%) patients were in New York Heart Association functional class III\/IV, which was significantly improved compared with the preoperative state (541\/692 vs. 14\/682, p &lt; 0.01). Conclusions: Ventricular septectomy combined with mitral valve repair can be a safe and effective treatment option for patients suffering from HOCM with SAM and severe MR.<\/jats:p>","DOI":"10.31083\/j.rcm2409268","type":"journal-article","created":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T08:20:03Z","timestamp":1695543603000},"source":"Crossref","is-referenced-by-count":3,"title":["Septal Myectomy and Subvalvular Repair in Hypertrophic Cardiomyopathy, a Systematic Review and Pooled Analysis"],"prefix":"10.31083","volume":"24","author":[{"given":"Ming-Yang","family":"Song","sequence":"first","affiliation":[{"name":"Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Wei","sequence":"first","affiliation":[{"name":"Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, Hubei, China"},{"name":"Key Laboratory of Organ Transplantation, Ministry of Education, 430010 Wuhan, Hubei, China"},{"name":"NHC Key Laboratory of Organ Transplantation, 430073 Wuhan, Hubei, China"},{"name":"Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, 430010 Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-He","family":"Li","sequence":"first","affiliation":[{"name":"Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Li","sequence":"first","affiliation":[{"name":"Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, Hubei, China"},{"name":"Key Laboratory of Organ Transplantation, Ministry of Education, 430010 Wuhan, Hubei, China"},{"name":"NHC Key Laboratory of Organ Transplantation, 430073 Wuhan, Hubei, China"},{"name":"Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, 430010 Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Maron BJ, Rowin EJ, Maron MS. Global Burden of Hypertrophic Cardiomyopathy. JACC: Heart Failure. 2018; 6: 376\u2013378.","DOI":"10.1016\/j.jchf.2018.03.004"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). European Heart Journal. 2014; 35: 2733\u20132779.","DOI":"10.1093\/eurheartj\/ehu284"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et al. American College of Cardiology\/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Journal of the American College of Cardiology. 2003; 42: 1687\u20131713.","DOI":"10.1016\/S0195-668X(03)00479-2"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Reis RL, Bolton MR, King JF, Pugh DM, Dunn MI, Mason DT. Anterion-superior displacement of papillary muscles producing obstruction and mitral regurgitation in idiopathic hypertrophic subaortic stenosis. Operative relief by posterior-superior realignment of papillary muscles following ventricular septal myectomy. Circulation. 1974; 50: II181\u2013II188.","DOI":"10.1161\/01.CIR.50.5.897"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Sherrid MV, Balaram S, Kim B, Axel L, Swistel DG. The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy: A Test in Context. Journal of the American College of Cardiology. 2016; 67: 1846\u20131858.","DOI":"10.1016\/j.jacc.2016.01.071"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Cho YH, Quintana E, Schaff HV, Nishimura RA, Dearani JA, Abel MD, et al. Residual and recurrent gradients after septal myectomy for hypertrophic cardiomyopathy-mechanisms of obstruction and outcomes of reoperation. The Journal of Thoracic and Cardiovascular Surgery. 2014; 148: 909\u2013915; discussion 915\u2013916.","DOI":"10.1016\/j.jtcvs.2014.05.028"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Klues HG, Maron BJ, Dollar AL, Roberts WC. Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation. 1992; 85: 1651\u20131660.","DOI":"10.1161\/01.CIR.85.5.1651"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Balaram SK, Ross RE, Sherrid MV, Schwartz GS, Hillel Z, Winson G, et al. Role of mitral valve plication in the surgical management of hypertrophic cardiomyopathy. The Annals of Thoracic Surgery. 2012; 94: 1990\u20131997; discussion 1997\u20131998.","DOI":"10.1016\/j.athoracsur.2012.06.008"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Vriesendorp PA, Schinkel AFL, Soliman OII, Kofflard MJM, de Jong PL, van Herwerden LA, et al. Long-term benefit of myectomy and anterior mitral leaflet extension in obstructive hypertrophic cardiomyopathy. The American Journal of Cardiology. 2015; 115: 670\u2013675.","DOI":"10.1016\/j.amjcard.2014.12.017"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Afanasyev AV, Bogachev-Prokophiev AV, Zheleznev SI, Sharifulin RM, Zalesov AS, Budagaev SA. Edge-to-Edge Repair Versus Secondary Cord Cutting During Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy: A Pilot Randomised Study. Heart, Lung & Circulation. 2021; 30: 438\u2013445.","DOI":"10.1016\/j.hlc.2020.05.106"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Kwon DH, Smedira NG, Thamilarasan M, Lytle BW, Lever H, Desai MY. Characteristics and surgical outcomes of symptomatic patients with hypertrophic cardiomyopathy with abnormal papillary muscle morphology undergoing papillary muscle reorientation. The Journal of Thoracic and Cardiovascular Surgery. 2010; 140: 317\u2013324.","DOI":"10.1016\/j.jtcvs.2009.10.045"},{"key":"ref12","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. British Medical Journal. 2021; 372: n71."},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine. 2009; 6: e1000097.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ Journal of Surgery. 2003; 73: 712\u2013716.","DOI":"10.1046\/j.1445-2197.2003.02748.x"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Liu F, Wang Y, Yang Y, Lai H, Song K, Wang C, et al. Myectomy with and without Mitral Subvalvular Repair in Patients with Hypertrophic Obstructive Cardiomyopathy with Grade 3 to 4+ Mitral Regurgitation without Intrinsic Mitral Valve Disease: A Retrospective Observational Study. Reviews in Cardiovascular Medicine. 2022; 23: 279.","DOI":"10.31083\/j.rcm2308279"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Ram E, Schwammenthal E, Kuperstein R, Jamal T, Nahum E, Sternik L, et al. Secondary chordal resection with septal myectomy for treatment of symptomatic obstructive hypertrophic cardiomyopathy. European Journal of Cardio-Thoracic Surgery. 2021; 60: 699\u2013707.","DOI":"10.1093\/ejcts\/ezab116"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Minakata K, Dearani JA, Nishimura RA, Maron BJ, Danielson GK. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae. The Journal of Thoracic and Cardiovascular Surgery. 2004; 127: 481\u2013489.","DOI":"10.1016\/j.jtcvs.2003.09.040"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Raffa GM, Franca EL, Lachina C, Palmeri A, Kowalewski M, Lebowitz S, et al. Septal Thickness Does Not Impact Outcome After Hypertrophic Obstructive Cardiomyopathy Surgery (Septal Myectomy and Subvalvular Mitral Apparatus Remodeling): A 15-Years of Experience. Frontiers in Cardiovascular Medicine. 2022; 9: 853582.","DOI":"10.3389\/fcvm.2022.853582"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Bogachev-Prokophiev A, Afanasyev AV, Zheleznev S, Pivkin A, Sharifulin R, Kozmin D, et al. Septal Myectomy With Vs Without Subvalvular Apparatus Intervention in Patients With Hypertrophic Obstructive Cardiomyopathy: A Prospective Randomized Study. Seminars in Thoracic and Cardiovascular Surgery. 2019; 31: 424\u2013431.","DOI":"10.1053\/j.semtcvs.2019.01.011"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Dorobantu LF, Iosifescu TA, Ticulescu R, Greavu M, Alexandrescu M, Dermengiu A, et al. Transaortic Shallow Septal Myectomy and Cutting of Secondary Fibrotic Mitral Valve Chordae-A 5-Year Single-Center Experience in the Treatment of Hypertrophic Obstructive Cardiomyopathy. Journal of Clinical Medicine. 2022; 11: 3083.","DOI":"10.3390\/jcm11113083"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Ferrazzi P, Spirito P, Iacovoni A, Calabrese A, Migliorati K, Simon C, et al. Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy. Journal of the American College of Cardiology. 2015; 66: 1687\u20131696.","DOI":"10.1016\/j.jacc.2015.07.069"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Schoendube FA, Klues HG, Reith S, Flachskampf FA, Hanrath P, Messmer BJ. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. Circulation. 1995; 92: II122\u2013II17.","DOI":"10.1161\/01.CIR.92.9.122"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Zyrianov A, Spirito P, Abete R, Margonato D, Poggio D, Vaccari G, et al. Impact of secondary mitral valve chordal cutting on valve geometry in obstructive hypertrophic cardiomyopathy with marked septal hypertrophy. European Heart Journal. Cardiovascular Imaging. 2023; 24: 678\u2013686.","DOI":"10.1093\/ehjci\/jeac179"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Schaff HV, Said SM. Transaortic Extended Septal Myectomy for Hypertrophic Cardiomyopathy. Operative Techniques in Thoracic and Cardiovascular Surgery. 2012; 17: 238\u2013250.","DOI":"10.1053\/j.optechstcvs.2012.04.002"},{"key":"ref25","unstructured":"Krajcer Z, Leachman RD, Cooley DA, Coronado R. Septal myotomy-myomectomy versus mitral valve replacement in hypertrophic cardiomyopathy. Ten-year follow-up in 185 patients. Circulation. 1989; 80: I57\u2013I64."},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Guigui SA, Torres C, Escolar E, Mihos CG. Systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: a narrative review. Journal of Thoracic Disease. 2022; 14: 2309\u20132325.","DOI":"10.21037\/jtd-22-182"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Levine RA, Vlahakes GJ, Lefebvre X, Guerrero JL, Cape EG, Yoganathan AP, et al. Papillary muscle displacement causes systolic anterior motion of the mitral valve. Experimental validation and insights into the mechanism of subaortic obstruction. Circulation. 1995; 91: 1189\u20131195.","DOI":"10.1161\/01.CIR.91.4.1189"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Kaple RK, Murphy RT, DiPaola LM, Houghtaling PL, Lever HM, Lytle BW, et al. Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. The Annals of Thoracic Surgery. 2008; 85: 1527\u20131535, 1535.e1\u2013e2.","DOI":"10.1016\/j.athoracsur.2008.01.061"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Patel P, Dhillon A, Popovic ZB, Smedira NG, Rizzo J, Thamilarasan M, et al. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography: Circulation. Cardiovascular Imaging. 2015; 8: e003132.","DOI":"10.1161\/CIRCIMAGING.115.003132"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Cape EG, Simons D, Jimoh A, Weyman AE, Yoganathan AP, Levine RA. Chordal geometry determines the shape and extent of systolic anterior mitral motion: in vitro studies. Journal of the American College of Cardiology. 1989; 13: 1438\u20131448.","DOI":"10.1016\/0735-1097(89)90326-4"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Raffa GM, Romano G, Turrisi M, Morsolini M, Gentile G, Sciacca S, et al. Pathoanatomic Findings and Treatment During Hypertrophic Obstructive Cardiomyopathy Surgery: The Role of Mitral Valve. Heart, Lung & Circulation. 2019; 28: 477\u2013485.","DOI":"10.1016\/j.hlc.2018.02.006"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Tao J, Duan F, Long J, Meng Q, Zhang B, Zhu Z, et al. The Role of the Submitral Apparatus in Hypertrophic Obstructive Cardiomyopathy. Journal of the American Society of Echocardiography. 2023; 36: 133\u2013145.","DOI":"10.1016\/j.echo.2022.09.018"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Beahrs MM, Tajik AJ, Seward JB, Giuliani ER, McGoon DC. Hypertrophic obstructive cardiomyopathy: ten- to 21-year follow-up after partial septal myectomy. The American Journal of Cardiology. 1983; 51: 1160\u20131166.","DOI":"10.1016\/0002-9149(83)90363-6"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"ten Berg JM, Suttorp MJ, Knaepen PJ, Ernst SM, Vermeulen FE, Jaarsma W. Hypertrophic obstructive cardiomyopathy. Initial results and long-term follow-up after Morrow septal myectomy. Circulation. 1994; 90: 1781\u20131785.","DOI":"10.1161\/01.CIR.90.4.1781"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Sasson Z, Prieur T, Skrobik Y, Fulop JC, Williams WG, Henderson MA, et al. Aortic regurgitation: a common complication after surgery for hypertrophic obstructive cardiomyopathy. Journal of the American College of Cardiology. 1989; 13: 63\u201367.","DOI":"10.1016\/0735-1097(89)90550-0"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Desai MY, Bhonsale A, Smedira NG, Naji P, Thamilarasan M, Lytle BW, et al. Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction. Circulation. 2013; 128: 209\u2013216.","DOI":"10.1161\/CIRCULATIONAHA.112.000849"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Hodges K, Rivas CG, Aguilera J, Borden R, Alashi A, Blackstone EH, et al. Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center. The Journal of Thoracic and Cardiovascular Surgery. 2019; 157: 2289\u20132299.","DOI":"10.1016\/j.jtcvs.2018.11.148"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Hong JH, Schaff HV, Nishimura RA, Abel MD, Dearani JA, Li Z, et al. Mitral Regurgitation in Patients With Hypertrophic Obstructive Cardiomyopathy: Implications for Concomitant Valve Procedures. Journal of the American College of Cardiology. 2016; 68: 1497\u20131504.","DOI":"10.1016\/j.jacc.2016.07.735"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Wei LM, Thibault DP, Rankin JS, Alkhouli M, Roberts HG, Vemulapalli S, et al. Contemporary Surgical Management of Hypertrophic Cardiomyopathy in the United States. The Annals of Thoracic Surgery. 2019; 107: 460\u2013466.","DOI":"10.1016\/j.athoracsur.2018.08.068"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Bogachev-Prokophiev A, Afanasyev A, Zheleznev S, Fomenko M, Sharifulin R, Kretov E, et al. Mitral valve repair or replacement in hypertrophic obstructive cardiomyopathy: a prospective randomized study. Interactive Cardiovascular and Thoracic Surgery. 2017; 25: 356\u2013362.","DOI":"10.1093\/icvts\/ivx152"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Afanasyev A, Bogachev-Prokophiev A, Lenko E, Sharifulin R, Ovcharov M, Kozmin D, et al. Myectomy with mitral valve repair versus replacement in adult patients with hypertrophic obstructive cardiomyopathy: a systematic review and meta-analysis. Interactive Cardiovascular and Thoracic Surgery. 2019; 28: 465\u2013472.","DOI":"10.1093\/icvts\/ivy269"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Lentz Carvalho J, Schaff HV, Nishimura RA, Ommen SR, Geske JB, Lahr BD, et al. Is anterior mitral valve leaflet length important in outcome of septal myectomy for obstructive hypertrophic cardiomyopathy? The Journal of Thoracic and Cardiovascular Surgery. 2023; 165: 79\u201387.e1.","DOI":"10.1016\/j.jtcvs.2020.12.143"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Pereda D, Topilsky Y, Nishimura RA, Park SJ. Asymmetric Alfieri\u2019s stitch to correct systolic anterior motion after mitral valve repair. European Journal of Cardio-Thoracic Surgery. 2011; 39: 779\u2013781.","DOI":"10.1016\/j.ejcts.2010.08.040"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Balaram SK, Tyrie L, Sherrid MV, Afthinos J, Hillel Z, Winson G, et al. Resection-plication-release for hypertrophic cardiomyopathy: clinical and echocardiographic follow-up. The Annals of Thoracic Surgery. 2008; 86: 1539\u20131544; discussion 1544\u20131545.","DOI":"10.1016\/j.athoracsur.2008.07.048"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Rodriguez F, Langer F, Harrington KB, Tibayan FA, Zasio MK, Cheng A, et al. Importance of mitral valve second-order chordae for left ventricular geometry, wall thickening mechanics, and global systolic function. Circulation. 2004; 110: II115\u2013II122.","DOI":"10.1161\/01.CIR.0000138580.57971.b4"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Rodriguez F, Langer F, Harrington KB, Tibayan FA, Zasio MK, Liang D, et al. Cutting second-order chords does not prevent acute ischemic mitral regurgitation. Circulation. 2004; 110: II91\u2013II97.","DOI":"10.1161\/01.CIR.0000138396.24335.6a"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Tang Y, Song Y, Duan F, Deng L, Ran J, Gao G, et al. Extended myectomy for hypertrophic obstructive cardiomyopathy patients with midventricular obstruction. European Journal of Cardio-Thoracic Surgery. 2018; 54: 875\u2013883.","DOI":"10.1093\/ejcts\/ezy203"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Wang S, Cui H, Yu Q, Chen H, Zhu C, Wang J, et al. Excision of anomalous muscle bundles as an important addition to extended septal myectomy for treatment of left ventricular outflow tract obstruction. The Journal of Thoracic and Cardiovascular Surgery. 2016; 152: 461\u2013468.","DOI":"10.1016\/j.jtcvs.2016.01.051"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Maron BJ, Dearani JA, Ommen SR, Maron MS, Schaff HV, Nishimura RA, et al. Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic Obstruction. Journal of the American College of Cardiology. 2015; 66: 1307\u20131308.","DOI":"10.1161\/circ.132.suppl_3.13977"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Panaich SS, Badheka AO, Chothani A, Mehta K, Patel NJ, Deshmukh A, et al. Results of ventricular septal myectomy and hypertrophic cardiomyopathy (from Nationwide Inpatient Sample [1998-2010]). The American Journal of Cardiology. 2014; 114: 1390\u20131395.","DOI":"10.1016\/j.amjcard.2014.07.075"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/24\/9\/10.31083\/j.rcm2409268","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T18:49:01Z","timestamp":1732733341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/24\/9\/10.31083\/j.rcm2409268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023]]}},"alternative-id":["S1530-6550(23)00968-7"],"URL":"https:\/\/doi.org\/10.31083\/j.rcm2409268","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,22]]},"article-number":"268"}}